Novo Nordisk ($NVO) announced an update on their ongoing clinical study. In a bid to address the persistent threat of coronary artery disease ...

Coronary artery disease (CAD) can reduce people’s life expectancy. However, this depends on various factors, including the severity of the condition, treatment efficacy, and whether the person has ...

The field of coronary artery disease saw its share of negative trials in 2024, but also got new guidelines, and a truce between interventionalists and surgeons. One long-awaited trial stood out: ...

Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular events in patients with suspected stable coronary artery disease.

A recent research letter published in the journal Nature Cardiovascular Research describes two new genetic loci associated with coronary artery calcification (CAC). CAC is a measure of atherosclerosis ...

A prospective, non-inferiority, randomised controlled TCW trial at 18 tertiary centres (2018-2023). Patients (n = 172) had severe aortic stenosis and complex coronary artery disease. They were ...

A recent review concluded The PREVENT equations provide updated risk models for assessing cardiovascular disease risk.

Unfortunately, we hear stories like this far too often: people who seem like the healthiest humans on the planet, only to ...

Both overweight and obesity can increase the risk of developing coronary artery disease. Maintaining a healthy diet and a moderate weight can help decrease the chance of this and other heart ...